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Timeliness of the investigation topic and the level of its development. Nowadays, 
more than 20 thousands of natural substances are described and hundreds of thousands of 
individual chemical compounds with antimicrobial properties are synthesized, which 
influence pathogens of various nature. However, a wide application of these drugs leads to a 
number of effects complicating the possibility of its rational use. They are: allergic 
reactions, serious toxic effect on the body, and development of drug resistance of pathogens 
to antimicrobial preparations being used.  
In this connection the investigations dedicated to purposeful search of high-efficient 
low-toxic drugs with a broad spectrum of activity among new promising antimicrobial 
agents become of great importance.  
Pyrimidine derivatives have been attracting attention of chemists-synthetics as well as that 
of specialists of adjacent areas for a long time due to a significant variety of their useful 
properties. A number of drugs on the basis of the pyrimidine derivatives are used in medical 
practice at present. They are applied as pharmaceuticals with antimicrobial, antiphlogistic, 
anticancer, regenerating and antimalarial properties (Машковский [Mashkovsky], 2012; 
Hugo et al., 1987). 
The compounds containing onium group have been arousing great interest of the 
researchers in the area of chemotherapy for a long time. Today they have wide applications: 
therapeutic antiseptics of local pyoinflammatory processes, prophylactic antiseptics for the 
intact skin before operations, antiseptics for mucous membranes; preservation of eye drops, 
injection solutions, tooth-pastes, cosmetic products, etc. Typical representatives of onium 
derivatives are: benzalkonium chloride, benzalkonium propionate, mecetronium methyl 
sulfate. Benzalkonium chloride has a broad spectrum of antimicrobial action in respect of a 
number of pathogens and forms a part of many famous drugs: pharmatex, benatex, septolete 
(Опарин [Oparin], 2003; РЛС Энциклопедия лекарств [RD Encyclopedia of drugs], 
2012). 
Antimicrobial activity of the onium compounds is a subject of a great number of 
publications (Корочкина и др. [Korochkina et al.], 2010; Корочкина и др. [Korochkina et 
al.], 2011; Кудрявцев и др.[Kudryavtsev et al.], 2011; Миргородская и др. 
[Mirgorodskaya et al.], 2011; Zhiltsova et al., 2012; Mirgorodskaya et al., 2014; Pashirova 
et al., 2015; Kenawy, 2007). However, there are practically no works dedicated to studies of 
antimicrobial activity of macrocyclic and acyclic onium derivatives of uracil. 
In this respect, the search of new original drugs with broad spectrum of antimicrobial 
activity and low toxicity to mammals in the series of macrocyclic and acyclic onium 
derivatives of uracil is of high importance. 
Consequently, the purpose of the given work is the investigation of antimicrobial 
and toxic properties of new macrocyclic and acyclic onium derivatives of uracil.  
The main objectives of the study: 
1. To characterize the antimicrobial activity macrocyclic and acyclic onium derivatives 
of uracil. 
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2. To analyze the relation “structure – activity” in the series of the compounds being 
investigated.   
3. To study the influence of onium derivatives of uracil on the activity of enzymes of 
dehydrogenases and lipases, as well as on the biosynthesis of biomarker ribosomal proteins 
Escherichia coli F 50. 
4. To estimate acute toxicity on laboratory mammals (mice, intraperitoneally).  
5. To investigate genotoxic and hemolytic properties macrocyclic and acyclic onium 
derivatives of uracil.  
6. To give a comparative estimation of the potential of practical application of 
macrocyclic and acyclic onium derivatives of uracil as antimicrobial agents.  
Scientific novelty. For the first time, antimicrobial activity of new chemical 
compounds has been studied, peculiarities of molecular structure have been determined, 
which provide low values of MIC (minimal inhibitory concentration) at the level of the 
known drugs (ciprofloxacin, ofloxacin, clotrimazole, amphotericin B, ketoconazole) and 
moderate values of toxicity on laboratory mice. The investigated compounds are not 
hemolytic agents. The Ames test has shown the absence of their genotoxicity. Macrocyclic 
and acyclic onium derivatives of uracil have been proposed to development as antimicrobial 
preparations. 
Practical significance of the work. The main practical achievement of the given 
work is determining in the series of macrocyclic and acyclic onium derivatives of uracil the 
compounds with high antimicrobial activity at the level of known standards. Macrocyclic 
and acyclic onium derivatives of uracil demonstrate selective properties against gram-
positive bacteria. Acyclic onium derivatives have turned out to be less specific and have 
shown high antimicrobial activity as against gram-positive and gram-negative bacteria, so 
against fungi. The results identified in conjunction with the data, indicating that the 
compounds studied have no mutagenic and hemolytic properties and demonstrate moderate 
toxic properties in relation to laboratory mice, open a prospect of using them to treat 
bacterial and fungal infections of humans and animals. 
Hypothesis to be defended  
1. Among 37 investigated compounds, the optimal combination of targeted 
antimicrobial and side toxic properties (acute toxicity, hemolytic activity, genotoxicity) 
appears in the series of acyclic derivatives of alloxazin.  
2. In relation to gram-positive bacteria macrocyclic and acyclic onium derivatives of 
uracil demonstrate antimicrobial activity at the level of ciprofloxacin and ofloxacin (MIC = 
0.2-3.9 mg/l); in relation to gram-negative bacteria the derivatives of hinzelin-2,4-dione and 
alloxazine are the most active (MIC = 3.1-31.3 mg/l); in relation to fungi the acyclic 
derivatives of alloxazine and uracil are the most active (MIC = 0.39 – 3.9 mg/l). 
3. Acyclic derivatives of alloxazine cause inhibition of the activity of dehydrogenases 
and lipases S. aureus 209-P and C. albicans 885-653 by (38-82%); all compounds studied 
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affect protein biosynthesis in cells E. coli F 50. 
Connection of the work with scientific programs and the author’s contribution into the 
investigation. The work has been implemented at the laboratory of chemical and biological 
investigations of A.E. Arbuzov Institute of Organic and Physical Chemistry of Kazan 
Scientific Center of Russian Academy of Science. It is a part of the investigations according 
to the direction of the Institute on state, budget themes “Synthesis and study of the structure, 
chemical and biological properties of microcyclic compounds containing pyrimidine and 
triazine fragments (№ of state registration 0120.0005796); “Functionalization of chelate and 
microcyclic compounds containing N-heteroaromatic and carbocyclic fragment, in order to 
give them practically useful properties” (№ of state registration 0120.0503489). The work is 
supported by the programs OCSM RAS “Chemistry and physicochemistry of 
supramolecular systems and atomic clusters”, “Biomolecular and medical chemistry”, 
“Medical chemistry”, by the program of the Presidium of RAS “Development of methods of 
obtaining chemical substances and creation of new materials”, by Federal target programs 
“Investigations and developments in priority directions of developing the scientific and 
technological complex of Russia on 2007-2012” (state contract № 02.513.12.0018), 
“Scientific and scientific-pedagogical personnel of innovative Russia” (agreement № 8432) 
and by the grants Russian Fund of Fundamental Investigations: № 07-03-00392-а 
“Amphiphilic macrocyclic compounds containing pyrimidine fragments: synthesis, 
catalysis, self-organization”, № 10-03-00365-а “Synthesis and properties of cryptan-like 
and nanoscale pyrimidinophanes”. 
Work approbation. The main results of the work were reported and discussed in the 
collection of articles “New drugs: progress and perspectives” (Ufa: Gilem, 2005); in the 
collection of articles “Chemistry and biological activity of synthetic and natural compounds, 
Nitrogen-containing heterocycles” (Moscow, 2006); on International symposium “Advances 
in synthetic and medicinal chemistry” (St. Petersburg, 2007); scientific conference “Organic 
chemistry for medicine” (Orhimed – 2008) (Moscow, 2008); scientific and practical 
conference “Biologically active substances: fundamental and applied issues of obtaining and 
application” (the Crimea, Ukraine, 2009); scientific and practical conference Biologically 
active substances: fundamental and applied issues of obtaining and application” (the 
Crimea, Ukraine, 2011); 47thInternational Conference on Medicinal Chemistry “Drug 
discovery and selection” (Lyon, France, 2011); International Congresson Organic 
Chemistry (Kazan, Russian Federation, 2011); 17thEuropean Symposiumon Organic 
Chemistry “ESOC 2011” (Hersonissos, Crete, Greece, 2011); on the first Russian 
conference on medical chemistry (MedChem Russia – 2013), (Moscow, 2013). 
Publications. On the thesis topic six works have been published, including three 
articles in international journals and three articles in Russian journals, which answer the 
requirements of State Commission for Academic Degrees and Titles.   
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Structure and volume of the thesis. The thesis consists of standard sections, they 
are: introduction, literature review, description of the materials and methods of the 
investigations, investigation results, their discussion, conclusions and references. The work 
is presented on 107 pages, contains 12 tables, 27 figures and the list of 116 references 
including Russian and foreign authors. 
Acknowledgement. The author would like to express her sincere gratitude to her research 
supervisor Doctor of Biological Science, Full Professor V.V. Zobov for support and 
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CONTENT OF THE WORK  
1. Materials and methods  
1.1. Compounds and test-objects used in the experiments  
As standards we used drugs of commercial origin (antibiotics substances of ciprofloxacin, 
ofloxacin, streptomycin, gramicidin S and antifungal agents of clotrimazole, ketoconazole, 
amphotericin В) (Sigma). Triethylmethylammonium bromide (a simple analog of the 
compounds being investigated, which has been studied in all test-systems as a model 
compound, containing the same specific pharmacophores (decile radical and onium group)), 
22 representatives of macrocyclic onium derivatives of uracil, 8 acyclic onium derivatives 
of uracil, 4 representatives of acyclic onium derivatives of hinzelin-2,4-dione and 3 
representatives of acyclic onium derivatives of alloxazin have been synthesized at the 
laboratory of chemistry of nucleotide bases of A.E. Arbuzov Institute of Organic and 
Physical Chemistry of Kazan Scientific Center of Russian Academy of Science.  
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Biological objects  
Strains of the test microorganisms, used in the work, are listed in Table 1. 
Table 1. 
№ Strains of bacteria  Strains of microscopic fungi 
1 Staphylococcus aureus АТСС 
209p 
Aspergillus niger BKMF-1119 
2 Bacillus cereus АТСС 8035 Trichophyton mentagrophytes var. 
gypseum 1773 
3 Escherichia coli CDC F-50 Candida albicans BKПГу-401/NCTC 
885-653 
4 Pseudomonas aeruginosa ATCC 
9027 
 
5 Enterococcus faecalis ATCC 
8043 
 
6 Salmonella typhimurium TA 100  
The bacteria have been obtained from the All-Russian collection of microorganisms 
strains State Scientific and research institute on standardization and quality control of drugs 
n.a. L.А. Tarasevich, Moscow, the fungi have been obtained from the All-Russian collection 
of pathogenic fungi (ARCPF), St.-Petersburg. 
To cultivate test microorganisms standard nutrient media have been used: Hottinger 
Broth for the bacteria and Sabouraud’s medium for fungi.  
1.2. Determination of antimicrobial activity of macrocyclic and acyclic onium 
derivatives of uracil  
Antimicrobial and antifungal activities have been determined by the method of serial 
dilution in liquid nutrient media, identifying the concentration of the compound being 
studied, under which total inhibition of test microorganism growth has been observed. This 
concentration (mg/l) has been marked as MIC (NCCLS, 2000; NCCLS, 1998).  
 1.3. Impact of macrocyclic and acyclic onium derivatives of uracil on 
biochemical processes of microorganisms  
1.3.1. Dehydrogenase activity of S. aureus 209p and C. albicans 885-653 has been 
determined in anaerobic conditions according to the time of decolorization of methylene 
blue by Thunberg method (Rajvaidya, 2006). 
1.3.2. Lipase activity S. aureus 209p and C. albicans 885-653 has been studied by 
the method based on titrimetric determination of free fatty acids generated as a result of 
hydrolysis of lipids (Ota’s and Yamada’s modified method) (Kashmiri, 2006; Macedo, 
1997). In the experiments, we used suspensions of the cultures S. аureus 209p and 
C. albicans 885-653 containing 1×109 cfu/ml. 
1.3.3. Spectra of the biomarker ribosomal protein Escherichia coli F-50 have been 
detected with MALDI-TOF mass spectrometer Autoflex («Bruker Daltonics», Germany). 
As a control sample, as well as an external calibrator a standard set of proteins of the firm 
«Bruker Daltonics» (Germany) has been used. To obtain each mass spectrum, we have used 
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from 1400 to 2000 impulses of the laser with of radiant flux power, fixed at minimal 
threshold value that has been sufficient for desorption-ionization of the sample. The mass 
spectrometer parameters have been optimized for the m/z range from 3000 to 100000 Da. 
For each sample, we have registered a spectrum obtained in the result of summation of 10 
single spectra (1400-2000 laser impulses). For the detection, we have used the software 
FlexControl 2.4 (Build 38), while to process and analyze mass spectra – FlexAnalysis 2.4 
(Build 11) of the firm «Bruker Daltonics» (Germany).  
The suspension of the cells of E.coli F-50 (1×109 cfu/ml) has been inhibited within 
24 hours with the solution of the compounds being studied in effective concentrations. After 
that, mass spectra of ribosomal proteins of the given culture have been obtained. The results 
have been estimated according to decrease or total disappearance of spectral peaks. 
As a positive control, we used samples containing a standard inhibitor of the protein 
synthesis, that is, the antibiotic streptomycin.  
1.4. Estimation of compounds acute toxicity  
The test on estimation of acute toxicity has been carried out on laboratory mammals: 
white outbred mice of both sexes with the body weight 19.0±2.0 g. The animals have been 
kept on a standard diet under natural lightning at temperature of 20±2oС (Руководство по 
экспериментальному (доклиническому) изучению новых фармакологических веществ 
[Reference book on experimental (preclinical) study of new pharmacological substances], 
2005). 
The initial toxicological estimation of the compounds (in the framework of the flow 
screening) at intraperitoneal method of injection of water solutions (or with addition of 0.2 
% of tween-80) has been carried out during acute experiments on mice of both sexes with 
the body weight 19.0±2.0 g. After that, during the next 72 hours, we have been observing 
the mice state, and registering the intoxication symptoms. The toxicity was estimate 
indicator LD50, that is, a dose (in µm), under which lethal outcome of 50 % of animals has 
been observed. To determine LD50, each compound has been injected to four groups of 
mice (6 animals for each dose; n=24). The conversion of doses from µm to mg/kg has been 
made according to the formula:  
[mg/kg] = (µm × molecular mass) / 1000 
All the compounds studied have been ranked in accordance with the classification of 
acute toxicity of substances when injecting into peritoneal cavity of an animal (Измеров и 
др. [Izmerov et al.], 1977). 
1.5. Estimation of hemolytic activity of macrocyclic and acyclic onium 
derivatives of uracil  
The estimation of hemolytic action of the compounds being investigated was carried 
out according to Russian National Standard of International Standards Organization 
10993.4-99. The method is based on the comparison of density of the solution of the 
substance being studied with blood with the optical density of blood at 100 % hemolysis. 
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For the investigation 10 % suspension of human erythrocytes (I «+») and those of the 
sheep. 
1.6. Determination of genotoxicity of macrocyclic and acyclic onium derivatives 
of uracil  
Drugs ability to induce gene mutations in cells was determined with Ames test 
without metabolic activation according to reversion of the test-strain Salmonella 
typhimurium TA 100 which is histidine auxotrophic to prototrophy (Ames et al., 1973; 
Maron, Ames, 1983). 
1.7. Statistical analysis of the results obtained was carried out using the programs 
Microsoft Office Excel 2007. The accuracy of differences of average values was estimated 
using Student’s coefficient (P≤0.05). The interrelation of series of data was determined with 
the help of the correlation coefficient. Table and graphical data contain average values and a 
standard error. 
2. INVESTIGATION RESULTS  
2.1. Determination of antimicrobial action of the compounds being investigated  
 2.1.1. Antimicrobial activity of macrocyclic onium derivatives of uracil 
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Fig. 1. General formula of macrocyclic onium derivatives of uracil (M) 
Table 2. Antimicrobial activity of macrocyclic onium derivatives of uracil 
Minimal Inhibitory Concentration (MIC) (mg/l) 
Gram-positive Gram-negative Fungi   
№ 
 
 
n R S. 
aureus 
B. 
cereus 
E. 
faecalis 
E. 
coli 
P. 
aeru 
ginosa 
A. niger 
T. menta 
gro 
phytes 
 
C. 
аlbi 
cans 
(4) 5 H 0.97 ±0,09 
1.95 
±0.19 
500 
±49 
62.5 
±5.8 
500 
±49 
250 
±25 
125 
±12 
125 
±12 
(5) 6 H 0.97 ±0.09 
1.95 
±0.18 
156.0 
±16 
62.5 
±6.2 
500 
±49 
250 
±24 
125 
±12 
125 
±12 
(6) 5 All 0.24 ±0.02 
3.9 
±0.4 
390 
±39 
15.6 
±1.5 
250 
±25 
250 
±24 
6.25 
±0.62 
1.9 
±0.2 
Triethyldecyl  
ammonium 
bromide  
2.5 
±0.2 
50 
±4.5 — 
156 
±12 — — 
500 
±41 
62.5 
±4.9 
Ciprofloxacin 0.25 ±0.02 
0.25 
±0.02 
3.9 
±0.4 
0.50 
±0.05
0.50 
±0.05    
Ofloxacin 0.97 ±0.09 
1.5 
±0.1 
15.6 
±1.5 
0.50 
±0.05
3.1 
±0.3    
Ketonazole       3.9 ±0.4 
3.9 
±0.4 
(— ) MIC >500 mg/l, All – allyl radical (CH2=CH-CH2) 
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Antimicrobial activity of macrocyclic onium derivatives of uracil was observed 
within the limits (0.24–500) mg/l. Table 2 presents the values of MIC of the most active 
macrocyclic derivatives of uracil. Compound 6, containing allyl radical in the 5th position of 
the uracil fragment, showed antibacterial activity against S. aureus 209 P on ciprofloxacin 
level (MIC – 0.24 mg/l). Antifungal activity of the given compound against C. albicans 
885–653 is twice higher than the value of activity of the antifungal drug ketonazole. 
Compounds 4 and 5 with unsubstituted 5th position in the uracil fragment turned out be 
specific to gram-positive bacteria (S. aureus 209 P and B. сereus 8035), antimicrobial 
activity was exhibited on the level of the antibiotic ofloxacin (MIC – 0.97 mg/l). High 
values of the activity were not indicated against E. faecalis 8043 and gram-negative bacteria 
(MIC 156–500 mg/l).  
2.1.2. Antimicrobial activity of acyclic onium derivatives of uracil 
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Table 3. Antimicrobial activity of acyclic onium derivatives of uracil 
 
Minimal Inhibitory Concentration (MIC) (mg/l) 
Gram-positive Gram-negative Fungi 
№ R1 R2 S. 
aureus 
B. 
cereus 
E. 
 
faecalis 
E. 
 coli 
P.  
aeru 
ginosa 
A.  
niger 
T. 
  enta‐ 
gro 
phytes 
 
C. 
аlbi 
cans 
(7) NO2 H 0.97 
±0.09 
15.6 
±1.5 
125 
±12 
15.6 
±1.6 — — 
31.3 
±3.0 
0.97 
±0.09 
(8) CH3 H 0.97 
±0.09 
6.3 
±0.6 
125 
±12 
15.6 
±1.5 
500 
±49 
125 
±12 
12.5 
±12 
0.97 
±0.09 
(9) C10H21 CH3 0.97 
±0.09 
0.50 
±0.05 
125 
±12 
62.5 
±6.2 
250 
±25 
500 
±50 
62.5 
±6.0 
0.97 
±0.09 
Triethyldecyl  
ammonium bromide 
2.5 
±0.2 
50 
±4.5 — 
156 
±12 — — 
500 
±41 
62.5 
±4.9 
Ofloxacin 0.97 ±0.09 
1.5 
±0.1 
15.6 
±1.5 
0.50 
±0.05 
3.1 
±0.3 
   
Amphotericin В      20.0 
±1.9 
3.1 
±3.0 
0.97 
±0.09 
(— ) MIC >500 mg/l  
Antimicrobial activity of acyclic onium derivatives of uracil was observed in the 
concentration range (0.5–500) mg/l. Compounds 7, 8 and 9 showed antibacterial activity 
against S. aureus 209 P and B. сereus 8035 on ofloxacin level, while antifungal activity was 
exhibited against C. albicans 885-653  at the level of the drug amphotericin B  (MIC – 
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0.97 mg/l). Compound 9, containing decyl radical (C10H21) in the 5th position of the uracil 
fragment, appeared to be the most active. The value of the activities against E. faecalis 8043 
and gram-negative bacteria is much lower, as well as in case of macrocyclic derivatives 
(Table 3). 
2.1.3. In the series of acyclic onium derivatives of hinzelin-2,4-dione, compound 12 
was obtained, which had a high antibacterial activity against gram-positive bacteria, 
including E. faecalis. MIC values were exhibited on ciprofloxacin level. 
Compound 12 is less active against gram-negative bacteria, but the highest 
antibacterial activity was observed against P. аeruginosa 9027 (MIC – 31.3 mg/l) in 
comparison with macrocyclic and acyclic onium derivatives of uracil. However, antifungal 
properties of hinzelin-2,4-dione derivatives yield significantly to the compounds described 
above (Table 4). 
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Table 4. Antimicrobial activity of acyclic onium derivatives of hinzelin-2,4-dione 
 
Minimal Inhibitory Concentration (MIC) (mg/l) 
Gram-positive Gram-negative Fungi 
№ 
 
R 
 S. 
aureus 
B. 
cereus 
E. 
faecalis 
E. 
 coli 
P. 
 aeru- 
ginosa 
A. 
niger 
T. 
 menta‐ 
gro 
phytes 
 
C. 
аlbi 
cans 
(10) C16H33
250 
±25 
500 
±49 — — — — — — 
(11) C5H11
31.3 
±3.0 
125 
±12 
500 
±49 — — — 
62.5 
±6.1 
62.5 
±6.2 
(12) C10H21
0.20 
±0.02 
1.95 
±0.19 
3.9 
±0.4 
15.6 
±1.5 
31.3 
±3.0 
250 
±25 
31.3 
±3.0 
31.3 
±3.1 
Triethyldecyl  
ammonium 
bromide  
 
2.5 
±0.2 
50 
±4.5 — 
156 
±12 — — 
500 
±41 
62.5 
±4.9 
Ciprofloxacin 0.25 ±0.02 
0.50 
±0.05 
3.9 
±0.4 
0.50 
±0.04 
0.50 
±0.05 - - - 
Ketoconazole - - - - - - 3.9 ±0.4 
3.9 
±0.4 
 (— ) MIC >500 mg/l 
2.1.4. Acyclic onium derivatives of alloxazin, as well as acyclic onium derivatives of uracil 
showed high antimicrobial activity against gram-positive bacteria and fungi (Table 5). 
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Antibacterial activity of compounds 14 and 15 against S. aureus 209 P and B. сereus 8035 
was exhibited on the level of ciprofloxacin and ofloxacin. Compound 14 showed the highest 
antifungal activity among all compounds investigated. Against C. albicans 885-653,  the 
activity of this compound  was exhibited on clotrimazole level, while its activity against 
T. mentagrophytes  1773  was  8 times higher than the MIC value of the known antifungal 
agent. 
 
 
 
 
 
 
Fig.4. General formula acyclic onium derivatives of alloxazin (AL) 
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Table 5. Antimicrobial activity of acyclic onium derivatives of alloxazin 
 
Minimal Inhibitory Concentration (MIC) (mg/l) 
Gram-positive Gram-negative Fungi  
 
№ 
 
 
n R S.  
aureus 
B.  
cereus
E. 
 
faecalis
E. 
 coli 
P. 
aeru 
ginosa 
A. 
  niger 
T. 
menta
gro 
phytes
 
C. 
albi 
cans 
(13) 5 С2Н5 — — — — — — — — 
(14) 5 C10H21 0.24 
±0.02 
0.24 
±0.02 
500 
±49 
3.1 
±0.3 
125 
±12 
125 
±12 
0.39 
±0.04 
0.39 
±0.03 
(15) 6 C10H21 0.97 
±0.09 
1.5 
±0.14 — 
12.5 
±1.2 
500 
±48 — 
1.9 
±0.1 
1.9 
±0.1 
Triethyldecyl  
ammonium bromide 
2.5 
±0.2 
50 
±4.5 — 
156 
±12 — — 
500 
±41 
62.5 
±4.9 
Ciprofloxacin 0.25 
±0.02 
0.25 
±0.02 
3.9 
±0.4 
0.50 
±0.05 
0.50 
±0.05 
- - - 
Ofloxacin 0.97 ±0.09 
1.5 
±0.1 
15.6 
±1.5 
0.50 
±0.05 
3.1 
±0.3 
- - - 
Clotrimazole - - - - - - 3.1 
±0.3 
0.39 
±0.03 
(— ) MIC >500 mg/l 
  
2.2. Estimation of the influence of macrocyclic and acyclic onium derivatives of 
uracil on biochemical processes of microorganisms  
 2.2.1. Effect of the compounds being studied on dehydrogenases and lipases of 
S. aureus 209-P and C. albicans 885-653 
In contrast to triethylmethylammonium bromide, all investigated compounds begin 
inhibiting dehydrogenase activity of S. aureus 209-P at the range of low concentrations 
0.05-5 mg/l (Fig. 5а). Alloxazin derivatives in concentration 0.5 mg/l inhibit the enzyme 
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action on 47 %, while in concentration 5 mg/l – on 60 %. Dehydrogenase activity of 
C. albicans 885-653 is most strongly inhibited by the derivatives of hinzelin-2,4-dione and 
alloxazin (Fig. 5b). In concentration 0.05 mg/l, the percentage of inhibition was 29 % and 
22 %, in concentration 0.5 mg/l – 48 % and 36 %, while in concentration 5 mg/l – 55 % and 
70 % respectively. Triethyldecyl ammonium bromide inhibits insignificantly dehydrogenase 
activity of C. albicans 885-653 only in high concentration 500 mg/l. Lipase activity of 
S. aureus 209-P is most actively inhibited by the derivatives of alloxazin (in concentration 
0.5 mg/l – on 72 %, 5 mg/l – on 82 %) (Fig. 5c). The rest of compounds are less active 
against of this enzyme. On lipase activity of C. albicans 885-653, the derivatives of 
alloxazin have the strongest impact (in concentration 5 mg/l – inhibition is 38 %) (Fig. 5d).  
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Fig. 5. Effect of the compounds being studied on dehydrogenase and lipase activity of S. aureus 
209-P and C. albicans 885-653. МС – model compound (Triethyldecyl ammonium bromide); М – 
macrocyclic onium derivative of uracil; А – acyclic onium derivative of uracil; H – acyclic onium 
derivative of hinzelin-2,4-dione; АL – acyclic onium derivative of alloxazin. 
2.2.2. Influence of macrocyclic and acyclic onium derivatives of uracil on the 
synthesis of biomarker ribosomal proteins Escherichia coli F 50  
Using the method of MALDI-TOF mass spectrometry we obtained mass spectra of 
ribosomal proteins E. coli F-50 with molecular mass of 9064, 9229, 9533 and 9735 Da 
(Fig. 6 А).  
After streptomycin affected the ribosomal proteins E. coli F-50 in MIC – 25 mg/l, the 
analysis of their mass spectra showed that the 1st peak, corresponding to protein S12 (mass 
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9064 Da), almost completely disappears (Fig. 6 B).  
Further the influence of representatives of each series of the investigated compounds 
in MIC on biosynthesis of ribosomal proteins E. coli F-50 was studied (Fig. 7 A). 
Triethyldecyl ammonium bromide (Fig.7 B) and acyclic onium derivative of uracil 
(compound 9) (Fig. 7 C), as well as streptomycin had a strong effect on the spectrum of 
ribosomal protein S12, so as on the 4th ribosomal (9735 Da). The derivatives of hinzelin-2,4-
dione and alloxazin contribute to the reduction of the spectra of the 2nd and 3rd ribosomal 
proteins with molecular masses of 9229, 9533 (compounds 12, 14) (Fig. 7 D, E).  
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Fig. 6. Influence of the antibiotic streptomycin on biosynthesis of biomarker ribosomal 
proteins Escherichia coli F 50: А) control – mass spectra of ribosomal proteins E. coli F-50 with 
molecular masses of 9064, 9229, 9533 and 9735 Da; B) streptomycin effect in MIC – 25 mg/l on 
biosynthesis of ribosomal proteins E. coli F-50). 
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Fig.7. Influence of macrocyclic and acyclic onium derivatives of uracil on biosynthesis of 
biomarker ribosomal proteins Escherichia coli F 50: А) control – mass spectra of ribosomal 
proteins E. coli F-50; B) influence of triethyldecyl ammonium bromide; C) influence of acyclic 
onium derivative of uracil (compound 9); D) influence of the derivative of hinzelin-2,4-dione 
(compound 12); E) influence of the derivative of alloxazin (compound 14). 
The effect of macrocyclic onium derivative of uracil with the highest antimicrobial 
activity (compound 6) leads to significant reduction of the spectrum of the 3rd ribosomal 
protein with molecular mass of 9533 Da (Fig. 8). 
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Fig. 8. Influence of macrocyclic onium derivative of uracil on biosynthesis of biomarker ribosomal 
proteins E. coli F-50: А) control – mass spectra of ribosomal proteins E. coli F-50; B) influence of 
macrocyclic onium derivative of uracil (6). 
2.3. Study of acute toxicity of macrocyclic and acyclic onium derivatives of uracil 
The estimation of acute toxicity was carried out for the compounds with high 
antimicrobial activity (Table 6). All the compounds tested fall into the category of 
“moderately toxic” (III class of danger according to the degree of the impact on the body).  
Table 6. Acute toxicity of the compounds investigated  
 
№ of the compound LD50; mg/kg, intraperitoneally, mice 
М-4 18.8  (16.3÷21.6) 
М-5 18.8  (16.3÷21.6) 
М-6 22.6  (19.9÷25.4) 
А-7 19.8  (17.3÷22.5) 
А-9 17.5  (15.6÷19.8) 
H-12 18.6  (16.1÷22.5) 
АL-14 20.9  (17.6÷24.7) 
АL-15 19.2  (14.9÷23.1) 
Triethyldecyl ammonium bromide 28.3  (22.9÷34.8) 
Gramicidin S 28.0  (25.4÷31.5) 
А 
B 
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М (4–6) – macrocyclic onium derivatives of uracil; А (7, 9) – acyclic onium derivatives of uracil; 
 H (12) acyclic onium derivative of hinzelin-2,4-dione; АL (14, 15) – acyclic onium derivatives of 
alloxazin. 
2.4. Estimation of hemolytic action of macrocyclic and acyclic onium derivatives of 
uracil 
From each series of the compounds being investigated, we selected a representative 
with the highest antimicrobial activity to estimate hemolytic action. The compounds were 
studied in minimal concentrations causing inhibition of growth of bacteria and fungi. 
According to Russian National Standard of International Standards Organization 10993 4-
99, if hemolysis is ≥ 2 %, the substance is considered to be hemolytically active. All the 
compounds tested do not have hemolytic action in the concentrations studied (Fig. 9).  
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Fig. 9. Hemolytic action of macrocyclic and acyclic onium derivatives of uracil. 
Compounds concentrations (mg/l): Triethyldecyl ammonium bromide (МС) – 62.5; macrocyclic 
onium derivative of uracil (М 6 ) – 15.6; acyclic onium derivative of uracil (А 9) – 0.97; derivative 
of hinzelin-2,4-dione (H 12) – 31.3; derivative of alloxazin (АL14) – 0.39, (PC) – positive control 
– 0.5 % NaCl. 
 
2.5. Genotoxic properties of macrocyclic and acyclic onium derivatives of uracil 
To estimate mutagenic effect, we used the same concentrations of the compounds 
being studied as when determining hemolysis. In the Ames test without metabolic activation 
it was shown that the number of His+ reverants being induced by onium compounds didn’t 
exceed spontaneous background of mutation (Fig. 10). 
As the number of colonies-reverants in experimental and control samples differ by 
less than 2.5 times, it can be considered that macrocyclic and acyclic onium derivatives of 
uracil do not have mutagenic activity in the concentrations being studied. 
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Fig. 10. Estimation of mutagenic effect of macrocyclic and acyclic onium derivatives of uracil.  
Compounds concentrations (mg/l): Triethyldecyl ammonium bromide (МС) – 62.5; macrocyclic 
onium derivative of uracil (М 6) – 15.6; acyclic onium derivative of uracil (А 9) – 0.97; derivative 
of hinzelin-2,4-dione (H 12) – 31,3; derivative of alloxazin (АL 14) – 0.39; PC – positive control 
(Na-azide); C – control (spontaneous background of mutation).  
3. DISCUSSION OF THE RESULTS  
3.1. Antimicrobial activity of macrocyclic and acyclic onium derivatives of uracil  
Macrocyclic onium derivatives of uracil are narrowly specific against gram-positive 
bacteria S. aureus 209-P and Bacillus сereus 8035. Such selectivity of action is apparently 
connected with tree-dimensional structure of their molecules, which correspondence to 
three-dimensional structure of the biotarget can provide possibility of selective and strong 
attachment. Large conformational homogeneity of microcyclic derivatives, in comparison to 
acyclic compounds, makes it possible to reach a certain biotarget without nonspecific losses. 
A lot of natural antibiotics and toxins, having a complicated cyclic structure, act in such 
way. 
It is obvious that antimicrobial activity of microcyclic derivatives is connected with 
the presence of pyrimidine fragment in their molecules. Apparently, in this case microcyclic 
derivatives of nucleotide bases act as nonspecific fragment, which intensifies antimicrobial 
action of specific pharmacophore (onium group containing lipophilic decyl radical) and 
even gives it new properties (selectivity in respect of gram-positive bacteria).  
Acyclic onium derivatives of uracil, as well as macrocyclic compounds, have high 
antibacterial activity against gram-positive bacteria. Moreover in respect of E. faecalis 8043 
antimicrobial activity of the majority of acyclic derivatives is 3 times higher than the most 
active macrocycle has.  
It was determined that acyclic onium derivatives of uracil appeared to be more active 
against fungi and gram-negative bacteria. Such changes of antimicrobial properties in 
direction of broadening the spectrum of action, possibly, are connected with lower 
conformational homogeneity of acyclic derivatives of uracil in comparison to macrocyclic 
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derivatives. 
Transfer to condensed derivatives of uracil, containing hinzelin-2,4-dione fragment, 
leads to appearance of selectivity in respect of bacteria and reduction of antifungal activity. 
Introduction of alloxazin fragment allowed obtaining a compound with the highest 
antimicrobial activity and broad spectrum of activity. 
Model compound (triethyldecyl ammonium bromide), which is a classical surface-
active substance, is significantly less active than all the compounds investigated.  
Thus, the influence of substituents nature at uracil fragment on antimicrobial activity 
is obvious, and the data obtained allow speaking about specific mechanism of action, which 
is determined directly by uracil fragment and structural peculiarities of the compound, not 
only by their solubilizing ability, which is observed in case of classical surface-active 
substances. 
The analysis of the relation “structure – activity” showed that the main structural 
factors influencing the antimicrobial activity of the compounds studied are: 1) presence of 
decyl radical in onium group composition; 2) penta- and hexamethylene chain between 
nitrogen atoms of onium group and N-heterocycle. 
3.2. Estimation of influence of macrocyclic and acyclic onium derivatives of uracil on 
biochemical processes of microorganisms  
3.2.1. Influence of macrocyclic and acyclic onium derivatives of uracil on the activity 
of dehydrogenases and lipases S. aureus 209-P and C. albicans 885-653. 
In view of the fact that metabolism in microorganisms cells is connected with 
enzymes activity and none of biochemical reactions takes place without them, it is obvious 
that the investigation of influence of various substances (including drugs) on cells metabolic 
processes is connected with the study of their impact on enzymatic processes.  
The experiments were carried out that made it possible to estimate the influence of 
the compounds being studied on such important enzymes in a cell as dehydrogenases and 
lipases, because the change of activity of the given enzymes reflects the dynamics of 
development of pathologic processes occurring in the organism. A lot of researchers note 
the inhibition of the activity of dehydrogenases and lipases of microorganisms by various 
antimicrobial and chemotherapeutic drugs (Очерки по микробиологии [Essays in 
Microbiology], 2011–2014), (Plewig, 1993).  
We carried out estimation of the influence of the compounds being studied on 
dehydrogenases and lipases S. aureus 209-P and C. albicans 885–653. The choice of tester 
strains was connected with the fact that these microorganisms appeared to be the most 
sensitive to all the compounds studied. 
The results obtained showed that in contrast to triethyldecyl ammonium bromide all 
the compounds studied inhibit actively enough dehydrogenases S. aureus 209-P and 
C. albicans 885–653.  
On the bases of these data it can be suggested that the action mechanism of the 
compounds studied is connected with inhibition of enzyme systems of the respiratory chain 
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of microorganisms at early stages of interaction with cellular targets, which disrupts normal 
flow of the synthesis of vital compounds in the microorganism cell. 
Lipases S. aureus 209-P and C. albicans 885–653 inhibit the derivatives of alloxazin 
most of all. The rest compounds are less active in respect of these enzymes. The influence 
of these series of compounds on microorganisms probably causes the disturbance of 
metabolic processes in cells connected with the action of lipolytic enzymes. 
3.2.2. Influence of macrocyclic and acyclic onium derivatives of uracil on 
synthesis of biomarker ribosomal proteins Escherichia coli F 50  
The use MALDI-TOF mass spectrometry method made it possible to give quite an 
exact illustration of the action mechanism of the known antibiotic streptomycin. The 
disappearance of the peak of S12 protein is in all probability an evidence of the disturbance 
of its synthesis in E . coli F 50 cells. 
Having obtained a clear picture of the known antibiotic effect on the synthesis of ribosomal 
proteins E. coli F 50, we made an attempt to study the influence of macrocyclic and acyclic 
onium derivatives of uracil on biosynthesis of biomarker ribosomal proteins E. coli F 50 
using MALDI-TOF mass spectrometry method. The analysis of the results obtained has 
made it possible to suggest that the action mechanism of the compounds studied is 
connected with the disturbance of protein synthesis in a bacterial cell. 
3.3. Estimation of acute toxicity, hemolytic action and genotoxic properties 
macrocyclic and acyclic onium derivatives of uracil 
The results obtained speak that all the compounds tested are related to the category of 
“moderately toxic” (III class of danger according to the degree of impact on the body). 
Toxic properties of the compounds being investigated are revealed on the level of the 
known antibiotic Gramicidin S, but in contrast to it onium derivative of uracil do not 
hemolytic action. Genotoxic properties have not been revealed in the Ames test among the 
series of macrocyclic and acyclic onium derivatives of uracil. 
Thus, the analysis of the results obtained showed that the compounds studied can be 
recommended for the work with living objects. 
 
AFTERWORD 
Macrocyclic and acyclic onium derivatives of uracil exhibited high antimicrobial 
activity on the level of the known drugs: ciprofloxacin, ofloxacin, clotrimazole, 
ketoconazole, amphotericin В. The connection between the structure of the compounds 
studied and their antimicrobial activity was determined. In the series of macrocyclic onium 
derivatives of uracil the compounds narrowly specific in respect of gram-positive bacteria 
were identified. Acyclic onium derivatives of uracil appeared to be less specific in respect of 
microorganisms used in the experiments and exhibited quite high antifungal activity on the 
level of widely used drugs: clotrimazole, ketoconazole and amphotericin В. The data on the 
study of the effect of macrocyclic and acyclic onium derivatives of uracil on biochemical 
processes of microorganisms have made it possible to suggest that the action mechanism of 
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these compounds is connected with inhibition of such important enzymes in a cell as 
dehydrogenases and lipases and protein biosynthesis. During the experiments it has been 
determined that all the compounds tested are related to the substance category of 
“moderately toxic”, do not exhibit hemolytic and mutagenic properties and can be applied 
for the work with living objects. 
Further investigations aimed at more thorough study of the action mechanism and 
new pharmacological properties will help develop a strategy for creating a new class of 
biologically active substances. 
CONCLUSIONS 
1. Against gram-positive bacteria, macrocyclic and acyclic onium derivatives of uracil 
exhibit antimicrobial activity on the level of ciprofloxacinand ofloxacin (MIC = 0.2-
3.9 mg/l); against gram-negative bacteria, acyclic derivatives of hinzelin-2,4-dione and 
alloxazin are the most active (MIC = 3.1-31.3 mg/l); against fungi, acyclic derivatives of 
alloxazin and uracil are the most active, which antifungal activity is shown on the level of 
ketoconazole, clotrimazole and amphotericin В (MIC = 0.39-3.9 mg/l).  
 2. The analysis of the relation “structure – activity” showed that macrocyclic onium 
derivatives of uracil exhibit selective properties against gram-positive bacteria. Acyclic 
onium derivatives appeared to be less specific and exhibited high antimicrobial activity as 
against gram-positive and gram-negative bacteria, so against fungi.  
The main structural factors, influencing antimicrobial activity of the compounds studied, 
are: 1) presence of decyl radical in composition of onium groups; 2) penta- and 
hexamethylene chains between nitrogen atoms of onium group and N-heterocycle. 
3. Maximal inhibition of the activity of dehydrogenases and lipases is reached under the 
action of alloxazin derivatives: of dehydrogenase activity of S. aureus 209-p is inhibited on 
60 %, Candida albicans 885-653 – on 70 %, lipase activity of S. aureus 209-p is inhibited 
on 82 %, C. albicans 885-653 – on 38 %. All the compounds studied influence protein 
biosynthesis in the cells of E. coli F 50. 
4. Macrocyclic and acyclic onium derivatives of uracil are related to the substance category 
of “moderately toxic” (mice, intraperitoneally in vivo). 
5. The compounds studied do not exhibit hemolytic and genotoxic properties in vitro.  
6. Macrocyclic and acyclic onium derivatives of uracil can be recommended for 
development as antimicrobial drugs, which are selective against gram-positive bacteria 
(macrocyclic derivatives), and have a broader spectrum of action (acyclic derivatives of 
alloxazin and uracil). 
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